The Swiss IMRT dosimetry intercomparison using a thorax phantom Results: Absolute dosimetry check under standard conditions: The mean ratio between the dose derived from the single field measurement and the stated dose, calculated with the treatment planning system, was 1.007 ± 0.010 for the ionisation chamber and 1.002 ± 0.014 (mean ± standard deviation) for the TLD measurements.
I. INTRODUCTION
A few years ago, IMRT (Intensity Modulated Radiation Therapy) was described as "a revolution in the treatment of cancer". 2 Now, IMRT is practiced in most radiotherapy centers and is accepted as an improvement on existing treatment techniques for several disease sites [3] [4] [5] .
Due to its complexity, IMRT is associated with a variety of uncertainties. 6, 7 Uncertainties leading to inaccurate dose delivery have implications on tumor control, treatment morbidity and toxicity. 8, 9 Thus, comprehensive quality assurance (QA) procedures are essential to check calculation and delivery. 10 For patient related QA, the validation of at least the data transfer and the intended dose to be delivered is important.
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In addition to the patient and machine related QA procedures performed by the institutions themselves, an audit organized by an independent external body is a fundamental step in any dosimetry QA program. 6 The audits provided by the European Society for Therapeutic Radiology and Oncology (ESTRO), the Radiological Physics Center (RPC) and other institutions comprise not only basic tests of the machine calibration, but they also check a substantial amount of the total therapy chain. [12] [13] [14] Ebert et al.
presented a comprehensive view on national and international studies and intercomparisons. 8 An intercomparison based on a standard patient represented by an anthropomorphic phantom enables an end to end test, i.e. all technical steps in the treatment chain can be checked. 8 In the hierarchical structure defined by Kron et al. 15 such kind of test is classified as Level III, while an intercomparison measuring the linear accelerator output under reference conditions in a regular phantom is referred to as Level I.
An issue often discussed is the ability of the dose calculation algorithms to properly take into account inhomogeneities, especially in low-density regions. Additionally, it is well known that dose calculation errors can be enhanced due to very small fields (< 4 cm edge length) which are typical for the IMRT technique. 1, [16] [17] [18] [19] [20] [21] This paper deals with the first such national intercomparison study held in Switzerland. All Swiss radiotherapy institutions participated in the study. Dose distributions in an anthropomorphous phantom with inhomogeneities were investigated. Calculations using different treatment planning systems were compared with measurements using different detectors.
Since an intercomparison was considered of general interest, the SSRMP (Swiss Society of Radiobiology and Medical Physics) decided to organize a national IMRT dosimetry intercomparison and offer it to all Swiss radio-oncology centers. The aim was to check multiple components of IMRT treatments using a thorax phantom provided with inhomogeneities. The intercomparison was organized by the physics team of the Cantonal Hospital St.Gallen which is responsible for all national dosimetric intercomparisons that have been performed in Switzerland since 2001. Switzerland participated in the Swiss IMRT intercomparison   between July 2008 and February 2009. A thorax phantom together with TLDs and ionization chamber inserts were sent to each participating center with a pre-defined time schedule. Two phantoms were used in a two week cycle. Detailed information on how to perform plans, calculations and measurements were also included. Each center had the possibility to perform ionization chamber measurements using their own equipment. It is legally required in Switzerland that all ionisation chamber calibrations have to be traceable to the National Primary Dosimetry Laboratory (METAS; Bundesamt für Metrologie und Akkreditierung). The 95% confidence interval of the METAS calibration for photon beams is 1.4% (at the date of the intercomparison). All errors are stated at one standard deviation of the mean of the quantity of interest.
II. MATERIALS AND METHODS

All 23 radiation oncology institutions in
II.A. Detectors
TLD-100 discs (4.5 mm Ø x 0.9 mm; Harshaw Inc.) were used together with a TLD reader model "5500" (Harshaw Inc.). The TLDs were tempered in a PTW-TLDO oven (PTW Freiburg). Reference irradiations were performed using a "Theratron 60" cobalt unit (AECL of Canada). An evaluation of consecutive reference irradiations has shown that the measurement reproducibility of one single TLD is better than 0.5% (1 SD). The measurement uncertainty for a detector consisting of five discs has been determined in the course of a preliminary study, which is described below.
Ionization chamber measurements were conducted by the individual centers using their own equipment.
II.B. Phantom
For the IMRT intercomparison, the thorax phantom 002LFC (CIRS Inc.) has been selected. The 
II.D.II. IMRT treatment
The computer tomography (CT) scans of the phantom were carried out by the individual institutions.
Since the phantom was already filled with TLDs when sent to the testing institutions, the applied CT dose also had to be measured.
Preparatory measurements confirmed that the dose within the phantom can be approximated with sufficient accuracy by the dose of the surface. Similar to the RPC (Radiological Physics Center) procedure 11 , surface dose was determined by strips of three TLDs each.
Furthermore one additional strip was provided in order to measure the background contribution during transport and storage. Doses accumulated by the TLD in those strips were subtracted from the total dose read from TLDs prior to analysis.
Two Perspex slices with cutouts for PTV and "heart" at the phantom longitudinal edges permitted an easy delineation of the PTV and the heart structures for the treatment planning (otherwise not visible).
The PTV and the heart are 8 cm long, while the lung and spinal cord structures cover the entire phantom length.
Centers were asked to prepare an IMRT plan fulfilling the following constraints:
• PTV: dose prescription (100%) to median PTV Dose = 2.00 Gy.
• Spinal cord: Maximum dose Dmax < 75% of the prescribed dose.
• Both lungs outside PTV: Less than 20% of each lung should receive more than 35% of the prescribed dose (D20% < 35%)
• Heart: Dmax < 55% of the prescribed dose.
The institutions were asked to irradiate the phantom hosting TLDs and ionization chamber according to this plan. The dose calculated by the treatment planning system (called Ds, stated dose) at each TLD and ion chamber measuring point were provided to the coordinating center in St.Gallen, along with the results of the ionization chamber measurements.
IMRT was the suggested technique, but other techniques have also been accepted. Some institutions carried out the calculation with two different calculation algorithms (five centers) or participated twice in the intercomparison by testing different machines (one center) or irradiation techniques (one center using IMRT or RapidArc). All plans used 6 MV beams.
Altogether 30 plan-measurement combinations were evaluated, and each is considered as independent in the present study. Twelve evaluations related to static IMRT (using static field segments), eleven to dynamic IMRT (using dynamic sliding window method or Rapid Arc), one to Tomotherapy and six to 3D-CRT irradiation techniques. A total of 24 machines have been tested.
For data analysis the percentage dose difference between stated and measured dose was reported:
(Dm-Ds)/Dprescribed, where Dm is the measured dose, Ds the stated dose and Dprescribed is the dose prescription of 2 Gy (median PTV dose). The "absolute difference" is defined by the expression (Dm-Ds)/Dprescribed .
For the evaluation, the algorithms used by the institutions have been classified as "type a" and "type b" algorithms, as defined by Knöös et al. 1 and Fogliata et al. 
III. RESULTS
III.A. Preliminary study
Apart from measurements close to the field edges, the absolute dose difference between MC dose calculations and TLD measurements is 0.9±0.6% in the normal tissue and 1.1±1.2% in lung, respectively
(1 SD). These values are in the same range as the measurement uncertainty of 0.6% to 0.9% observed in previous dosimetry intercomparisons in a water tank. Table 2 shows the ratio between the dose derived from the phantom measurement, Dm, and the stated dose under standard conditions, Ds. It is a measure of the linac calibration. The maximum deviation of the TLD measured dose to the stated dose is 3.2%. 24 of 28 TLD measurements (85%) agree better than 2% with the stated doses, which is an excellent result. No relevant differences between ionization chamber and TLD measurements have been found (p = 0.19) although a 0.5% higher measured value (on average) for ion chamber is present with respect to TLD. The TLD measurements show a larger standard deviation than the ionization chamber measurements. This is likely to be due to the lower precision of the TLD measurements compared to ionisation chamber measurements and due to linac calibration by the institutions, where the ionisation chamber system used for calibration can correspond to the one used in the IMRT intercomparison. No information about the uncertainty of the ionisation chamber measurements is available.
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III.B. IMRT dosimetry intercomparison
III.B.I. Linac calibration check
III.B.II. IMRT planning and treatment
A visual example of the results in terms of percentage dose differences is shown in figure 3 , for a "type a" (Eclipse, PBC) and a "type b" (Eclipse, AAA) algorithm for the same unit. Differences occur especially in the lung region with high doses (PTV), and in particular for the "type a" algorithm, as is to be expected. whereas the ionization chamber value is based on a single measurement point.
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The Swiss IMRT dosimetry intercomparison using a thorax phantom Pinnacle CCC (6) 0.4 ± 0.9 0.6 ± 0.6 0.2 ± 0.8 -0.5 ± 1.0 -0.1 ± 0.4 -1.1 ± 0.8
Eclipse AAA (5) -1.8 ± 0.9 -1.8 ± 1.6 -1.0 ± 1.3 -1.5 ± 1.3 0.7 ± 0.9 0.4 ± 0.8
MasterPlan CCC (4) 0.2 ± 0.9 2.1 ± 0.6 1.6 ± 3.6 2.1 ± 2. Tomotherapy CS (1) -
Mann-Whitney-tests for both TLD and ionization chamber measurements in the PTV prove that "type b" algorithms are superior to "type a" in calculating the dose in the lung region within the PTV, with p < 0.001. Table 4 shows the percentage dose difference in regions outside the PTV: left and right lungs, normal soft tissue, heart and spinal cord (embedded in the bony-like structure). alg. The preliminary study, checking one single field against Monte Carlo simulations, proved the accuracy of the TLD measurements both in water and lung equivalent media to be sufficient. They were reliable and therefore suitable for the intercomparisons.
Additionally, ionisation chamber measurements were performed by the individual institutions, giving further and immediate information supporting the TLD results.
The specific check of the plan dose calculation and delivery chain gave valuable information to the participating centers. Additionally, the results from the intercomparison showed some interesting features, mainly differences between "type a" and "type b" dose calculation algorithms: With a multicenter intercomparison, where several and different TPS were used as well as different techniques, we confirmed that "type b" algorithms take inhomogeneities into account better than "type a". This finding coincides with other groups 25 .
Some "type a" algorithms show deviations between calculations and measurements of more than 5%
in the PTV region located in the lung area, with both TLDs and ionization chamber. The same pattern is detected in lung regions outside the PTV. A useful additional outcome of this dosimetry intercomparison, is that it gives the participating centers the opportunity to evaluate the degree of accuracy of their dose calculation algorithm when used in near clinical conditions. In particular two main points could be addressed. The first point concerns the cases where the target partially includes a low density medium: in this case a center running a "type a" algorithm is informed that the dose delivered to the PTV in the lung tissue could be about 5% lower than planned (and expected), with possible issues in terms of treatment outcome. The second point relates to the dose delivered to healthy lung tissue: the user needs to consider the issue of the tolerance dose level stipulated for the lung and the dose computed by their TPS, depending on whether the algorithm is a type "a" or "b". These dosimetric tests permit users a better understanding of their algorithm response in certain conditions and the possible consequences.
Within soft tissue, both "type a" and "b" algorithms present dose calculations which agree with the measurements within 2% of the prescribed dose, with no significant difference between the two types.
This finding coincides with other published results. 1, 18, 26 . The irradiation technique (3D-CRT, static or dynamic IMRT) has no influence on the agreement between measurements and calculations.
No information is available on the time needed for planning, irradiation and documentation of the intercomparison. But our own experiences show that the effort has been about three times larger than for a clinical IMRT plan.
The intercomparison focused on the currently available dose calculation algorithms. In 2008, MC was not available for routine planning in the institutions. Due to the rapid adoption of MC algorithm in the community with the increasingly powerful computing, the inclusion of MC will be an issue for future dosimetric intercomparisons.
Finally, it can be stated that all the treatment plans carried out by the Swiss radiotherapy centers fulfilled the requirements in terms of planning objectives. However, it has to be pointed out that relevant parts of the overall treatment chain cannot be checked in the frame of a dosimetry intercomparison. For this a more general intercomparison would be necessary including e.g. the diagnosis and the therapy concept, the delineation of the planning structures, the positioning of the patient and treated volume, etc.
It is the responsibility of the institutions to arrange and participate in advanced education and QA concepts including such tasks. These elements are subjects of ongoing investigations.
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V. CONCLUSION
The intercomparison procedure has turned out to be feasible and yields valuable convincing results.
In the future, the IMRT intercomparison will be repeated on a three years regular interval with modified objectives adapted to the current demands.
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